Friday, March 18, 2016, 69 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $197.20 to $47,685,000.00.

Highlighted Stocks Traded by Insiders:

Cancer Genetics (CGIX) - FREE Research Report

McLeod Howard, who is Director at Cancer Genetics, bought 1,000 shares at $2.71 on March 18, 2016. Following this transaction, the Director owned 6,000 shares meaning that the stake was boosted by 20% with the 1,000-share transaction.

The shares most recently traded at $3.14, up $0.43, or 13.69% since the insider transaction. Historical insider transactions for Cancer Genetics go as follows:

  • 4-Week # shares bought: 152,540
  • 4-Week # shares sold: 5,296
  • 12-Week # shares bought: 152,540
  • 12-Week # shares sold: 5,296
  • 24-Week # shares bought: 257,540
  • 24-Week # shares sold: 5,296

The average volume for Cancer Genetics has been 111,700 shares per day over the past 30 days. Cancer Genetics has a market cap of $35.1 million and is part of the health care sector and health services industry. Shares are down 15.45% year-to-date as of the close of trading on Friday.

Cancer Genetics, Inc., an oncology diagnostics company, focuses on developing and commercializing DNA-based tests and services to enhance and personalize the diagnosis, prognosis, and treatment of targeted cancers in the United States, India, and China. Currently, there are 2 analysts who rate Cancer Genetics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CGIX - FREE

TheStreet Quant Ratings rates Cancer Genetics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Cancer Genetics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Spirit Airlines (SAVE) - FREE Research Report

Elkins David G, who is Director at Spirit Airlines, bought 1,500 shares at $47.92 on March 18, 2016. Following this transaction, the Director owned 9,705 shares meaning that the stake was boosted by 18.28% with the 1,500-share transaction.

The shares most recently traded at $49.58, up $1.66, or 3.35% since the insider transaction. Historical insider transactions for Spirit Airlines go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 730
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 730
  • 24-Week # shares bought: 9,500
  • 24-Week # shares sold: 730

The average volume for Spirit Airlines has been 1.7 million shares per day over the past 30 days. Spirit Airlines has a market cap of $3.4 billion and is part of the services sector and transportation industry. Shares are up 23.76% year-to-date as of the close of trading on Friday.

Spirit Airlines, Inc. provides low-fare airline services. The company has a P/E ratio of 10.9. Currently, there are 8 analysts who rate Spirit Airlines a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAVE - FREE

TheStreet Quant Ratings rates Spirit Airlines as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Spirit Airlines Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Brooks Automation (BRKS) - FREE Research Report

Gray David C, who is Chief Strategy & New Business at Brooks Automation, sold 12,089 shares at $9.96 on March 18, 2016. Following this transaction, the Chief Strategy & New Business owned 145,275 shares meaning that the stake was reduced by 7.68% with the 12,089-share transaction.

The shares most recently traded at $10.11, up $0.15, or 1.52% since the insider transaction. Historical insider transactions for Brooks Automation go as follows:

  • 4-Week # shares bought: 20,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 13,000

The average volume for Brooks Automation has been 287,300 shares per day over the past 30 days. Brooks Automation has a market cap of $683.7 million and is part of the technology sector and electronics industry. Shares are down 5.52% year-to-date as of the close of trading on Friday.

Brooks Automation, Inc. provides automation and cryogenic solutions for semiconductor manufacturing and life sciences markets. It operates through three segments: Brooks Product Solutions, Brooks Global Services, and Brooks Life Science Systems. The stock currently has a dividend yield of 4%. The company has a P/E ratio of 55.5. Currently, there are 2 analysts who rate Brooks Automation a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BRKS - FREE

TheStreet Quant Ratings rates Brooks Automation as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and weak operating cash flow. Get the full Brooks Automation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.